HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers
Author's Correction ( vol. 84 , p. 1212 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribe...
Saved in:
Published in | Journal of Virology Vol. 83; no. 7; pp. 3407 - 3412 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.04.2009
American Society for Microbiology (ASM) |
Subjects | |
Online Access | Get full text |
ISSN | 0022-538X 1098-5514 1098-5514 |
DOI | 10.1128/JVI.02459-08 |
Cover
Abstract | Author's Correction
(
vol.
84
,
p.
1212
)
Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8(+) T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag, pol, and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection.Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8(+) T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag, pol, and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection. Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8(+) T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag, pol, and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection. Author's Correction ( vol. 84 , p. 1212 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment. Virus-specific cytotoxic CD8 + T lymphocytes are believed to play a crucial role in viral containment, but the degree of immune imprinting and compensatory mutations in EC is unclear. We obtained plasma gag , pol , and nef sequences from HLA-diverse subjects and found that 30 to 40% of the predefined HLA-associated polymorphic sites show evidence of immune selection pressure in EC, compared to approximately 50% of the sites in chronic progressors. These data indicate ongoing viral replication and escape from cytotoxic T lymphocytes are present even in strictly controlled HIV-1 infection. |
Author | Zabrina L. Brumme P. Richard Harrigan Chanson J. Brumme Alicja Trocha Mina John Brian L. Block Simon Mallal Mark A. Brockman Florencia Pereyra Toshiyuki Miura Bruce D. Walker |
AuthorAffiliation | Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, 1 Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, 2 Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, 3 Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia, 4 British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, 5 Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada 6 |
AuthorAffiliation_xml | – name: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, 1 Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, 2 Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, 3 Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia, 4 British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, 5 Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada 6 |
Author_xml | – sequence: 1 givenname: Toshiyuki surname: Miura fullname: Miura, Toshiyuki organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, Howard Hughes Medical Institute, Chevy Chase, Maryland 20815 – sequence: 2 givenname: Chanson J. surname: Brumme fullname: Brumme, Chanson J. organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129 – sequence: 3 givenname: Mark A. surname: Brockman fullname: Brockman, Mark A. organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115 – sequence: 4 givenname: Zabrina L. surname: Brumme fullname: Brumme, Zabrina L. organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115 – sequence: 5 givenname: Florencia surname: Pereyra fullname: Pereyra, Florencia organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115 – sequence: 6 givenname: Brian L. surname: Block fullname: Block, Brian L. organization: Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115 – sequence: 7 givenname: Alicja surname: Trocha fullname: Trocha, Alicja organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Howard Hughes Medical Institute, Chevy Chase, Maryland 20815 – sequence: 8 givenname: Mina surname: John fullname: John, Mina organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia – sequence: 9 givenname: Simon surname: Mallal fullname: Mallal, Simon organization: Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Australia – sequence: 10 givenname: P. Richard surname: Harrigan fullname: Harrigan, P. Richard organization: British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada, Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 11 givenname: Bruce D. surname: Walker fullname: Walker, Bruce D. organization: Ragon Institute (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charlestown, Massachusetts 02129, Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, Howard Hughes Medical Institute, Chevy Chase, Maryland 20815 |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21261644$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19153230$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks9v0zAcxS00xLqNG2dkDnBaNv-Oc0GqqkGLiriMiZvlOM7qybE7Oxnqf09Cu_FDQpwsy5_3_J79PQFHIQYLwCuMLjAm8vLTzeoCEcarAslnYIZRJQvOMTsCM4QIKTiV347BSc53CGHGBHsBjnGFOSUUzUC9XM-Lec7RON3bBt64pD38PPS6dzFkOE8WLmLXxQBdgMuh0wGuum4IsbGtM84Gs5tEQ4bXu62FGF5510-a0KfovU35DDxvtc_25WE9BV8_XF0vlsX6y8fVYr4uDKe8L7QUqOFS19rQEmvOq1riEssSCVTVDSONJFSWrTCWYCzGAi0xiI_bSlvccnoK3u99t0Pd2cbYMYH2aptcp9NORe3UnyfBbdRtfFBEcM6FHA3eHQxSvB9s7lXnsrHe62DjkJUoESaCof-CBFPERDWBr3-P9JTl8f1H4O0B0Nlo3yYdjMtPHBnvw4KxkTvfcybFnJNtf1khNY2BGsdA_RwDhaYm5C_cuP2PjsWd_5fozV60cbeb7y5ZpXOn7h6cklSVijJU0h8_Mb-z |
CitedBy_id | crossref_primary_10_1186_s12977_017_0354_5 crossref_primary_10_1016_j_virol_2012_10_004 crossref_primary_10_1016_j_immuni_2021_08_007 crossref_primary_10_1016_j_tips_2009_09_005 crossref_primary_10_1128_JVI_06982_11 crossref_primary_10_3389_fimmu_2015_00665 crossref_primary_10_1097_COH_0b013e328361faf4 crossref_primary_10_1371_journal_pone_0137140 crossref_primary_10_1146_annurev_conmatphys_030212_184325 crossref_primary_10_1371_journal_pone_0047818 crossref_primary_10_1371_journal_pone_0103209 crossref_primary_10_1016_j_coviro_2012_08_003 crossref_primary_10_1128_JVI_05841_11 crossref_primary_10_1080_21505594_2022_2129353 crossref_primary_10_1128_JVI_00460_11 crossref_primary_10_4049_jimmunol_0902781 crossref_primary_10_1016_j_pharma_2014_11_002 crossref_primary_10_1128_JVI_02438_09 crossref_primary_10_1016_j_pharma_2014_11_003 crossref_primary_10_1128_JVI_07020_11 crossref_primary_10_1016_j_meegid_2013_02_003 crossref_primary_10_1186_1742_4690_8_63 crossref_primary_10_1038_cmi_2012_50 crossref_primary_10_1038_nri3478 crossref_primary_10_1073_pnas_1105315108 crossref_primary_10_1038_464161a crossref_primary_10_1155_2012_153863 crossref_primary_10_1038_ni_3161 crossref_primary_10_1038_nm_4100 crossref_primary_10_1007_s00430_014_0372_z crossref_primary_10_1590_0074_02760230066 crossref_primary_10_1371_journal_pone_0063094 crossref_primary_10_1016_j_immuni_2011_07_005 crossref_primary_10_1128_JVI_00387_10 crossref_primary_10_1073_pnas_1302090110 crossref_primary_10_1128_JVI_01334_14 crossref_primary_10_1016_j_immuni_2012_09_005 crossref_primary_10_1089_vim_2009_0084 crossref_primary_10_1128_JVI_00803_10 crossref_primary_10_1016_j_heliyon_2024_e30900 crossref_primary_10_1038_s41577_020_0274_9 crossref_primary_10_1097_QAD_0b013e32835861b0 crossref_primary_10_1073_pnas_1221555110 crossref_primary_10_1128_JVI_01527_15 crossref_primary_10_1007_s00109_012_0892_1 crossref_primary_10_1097_QAD_0000000000003296 crossref_primary_10_1089_aid_2014_0040 crossref_primary_10_1016_j_antib_2010_04_001 crossref_primary_10_1155_2012_637208 crossref_primary_10_1097_COH_0b013e32832c0672 crossref_primary_10_1097_QAD_0b013e32833e5009 crossref_primary_10_1128_JVI_06728_11 crossref_primary_10_1128_JVI_06724_11 crossref_primary_10_1172_JCI171097 crossref_primary_10_1371_journal_ppat_1003423 crossref_primary_10_1111_imr_12076 crossref_primary_10_1007_s00705_010_0659_3 |
Cites_doi | 10.1128/JVI.01847-06 10.1128/jvi.68.7.4650-4655.1994 10.1128/JVI.80.10.4758-4770.2006 10.1038/nm1520 10.1038/nm0297-212 10.1038/ni1281 10.1084/jem.20031982 10.1128/JVI.01369-07 10.1128/JVI.01958-08 10.1086/514112 10.1128/JVI.00580-08 10.1073/pnas.94.5.1890 10.1128/JVI.77.12.6889-6898.2003 10.1128/JVI.00535-08 10.4049/jimmunol.174.12.7524 10.1128/JVI.02165-06 10.1097/QAD.0b013e3283021a8c 10.1128/JVI.80.10.5074-5077.2006 10.1084/jem.20052319 10.1128/JVI.02392-06 10.1128/JVI.01471-08 10.1371/journal.ppat.0030094 10.1126/science.283.5403.857 10.1128/JVI.80.6.3122-3125.2006 10.1086/526786 10.1038/nm0496-405 10.1128/JVI.77.4.2736-2740.2003 10.1038/nm992 10.1128/jvi.68.4.2362-2370.1994 10.1038/35030124 10.1128/JVI.80.7.3617-3623.2006 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS Copyright © 2009, American Society for Microbiology |
Copyright_xml | – notice: 2009 INIST-CNRS – notice: Copyright © 2009, American Society for Microbiology |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7U9 H94 7X8 5PM |
DOI | 10.1128/JVI.02459-08 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 3412 |
ExternalDocumentID | PMC2655568 19153230 21261644 10_1128_JVI_02459_08 jvi_83_7_3407 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R37 AI028568 – fundername: NIAID NIH HHS grantid: R01 AI030914 – fundername: Howard Hughes Medical Institute – fundername: NIAID NIH HHS grantid: AI028568 – fundername: NIAID NIH HHS grantid: R01 AI028568 – fundername: NIAID NIH HHS grantid: AI030914 – fundername: NIAID NIH HHS grantid: P30 AI060354 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM IQODW CGR CUY CVF ECM EIF NPM 7T5 7U9 H94 7X8 5PM |
ID | FETCH-LOGICAL-c535t-a860d58abac371a559b8171870609bd42d82387f6ce2116153f2c056ce9ae1f53 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 18:31:46 EDT 2025 Fri Sep 05 06:05:38 EDT 2025 Fri Sep 05 11:00:43 EDT 2025 Thu Apr 03 07:07:04 EDT 2025 Mon Jul 21 09:14:31 EDT 2025 Thu Apr 24 23:01:30 EDT 2025 Tue Jul 01 00:57:31 EDT 2025 Wed May 18 15:25:39 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Immunopathology HLA-System HIV-1 virus Retroviridae AIDS Immune deficiency Lentivirus Virology Infection Virus Viral disease Human immunodeficiency virus Mutation |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c535t-a860d58abac371a559b8171870609bd42d82387f6ce2116153f2c056ce9ae1f53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Corresponding author. Present address of Toshiyuki Miura: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. Phone: 81-3-5449-5338. Fax: 81-3-5449-5427. E-mail: miura523@hotmail.com. Mailing address for Bruce D. Walker: Room 5212, Ragon Institute, Massachusetts General Hospital, 149 13th St., Charlestown, MA 02129. Phone: (617) 724-8332. Fax: (617) 726-4691. E-mail: bwalker@partners.org |
OpenAccessLink | http://doi.org/10.1128/JVI.02459-08 |
PMID | 19153230 |
PQID | 21304690 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_67012640 crossref_primary_10_1128_JVI_02459_08 proquest_miscellaneous_21304690 highwire_asm_jvi_83_7_3407 crossref_citationtrail_10_1128_JVI_02459_08 pubmed_primary_19153230 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2655568 pascalfrancis_primary_21261644 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-04-01 |
PublicationDateYYYYMMDD | 2009-04-01 |
PublicationDate_xml | – month: 04 year: 2009 text: 2009-04-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2009 |
Publisher | American Society for Microbiology American Society for Microbiology (ASM) |
Publisher_xml | – name: American Society for Microbiology – name: American Society for Microbiology (ASM) |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 (e_1_3_2_17_2) 2008 15067030 - J Exp Med. 2004 Apr 5;199(7):905-15 J Virol. 2010 Jan;84(2):1212 12768008 - J Virol. 2003 Jun;77(12):6889-98 16369537 - Nat Immunol. 2006 Feb;7(2):173-8 16501126 - J Virol. 2006 Mar;80(6):3122-5 12552014 - J Virol. 2003 Feb;77(4):2736-40 14770175 - Nat Med. 2004 Mar;10(3):282-9 16641269 - J Virol. 2006 May;80(10):4758-70 17151109 - J Virol. 2007 Mar;81(5):2508-18 8207839 - J Virol. 1994 Jul;68(7):4650-5 9018241 - Nat Med. 1997 Feb;3(2):212-7 9359718 - J Infect Dis. 1997 Nov;176(5):1188-97 16641299 - J Virol. 2006 May;80(10):5074-7 18580606 - AIDS. 2008 Jul 11;22(11):1277-86 17251286 - J Virol. 2007 Apr;81(7):3465-76 15944251 - J Immunol. 2005 Jun 15;174(12):7524-30 16682496 - J Exp Med. 2006 May 15;203(5):1357-69 17182686 - J Virol. 2007 Mar;81(5):2440-8 16537629 - J Virol. 2006 Apr;80(7):3617-23 18596105 - J Virol. 2008 Sep;82(17):8548-59 11014195 - Nature. 2000 Sep 21;407(6802):386-90 8139022 - J Virol. 1994 Apr;68(4):2362-70 18945771 - J Virol. 2009 Jan;83(1):88-97 18971283 - J Virol. 2009 Jan;83(1):140-9 9933172 - Science. 1999 Feb 5;283(5403):857-60 17616974 - PLoS Pathog. 2007 Jul;3(7):e94 18275276 - J Infect Dis. 2008 Feb 15;197(4):563-71 18562530 - J Virol. 2008 Sep;82(17):8422-30 17173051 - Nat Med. 2007 Jan;13(1):46-53 17728232 - J Virol. 2007 Nov;81(22):12608-18 8597949 - Nat Med. 1996 Apr;2(4):405-11 9050875 - Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 |
References_xml | – ident: e_1_3_2_15_2 doi: 10.1128/JVI.01847-06 – ident: e_1_3_2_21_2 doi: 10.1128/jvi.68.7.4650-4655.1994 – ident: e_1_3_2_4_2 doi: 10.1128/JVI.80.10.4758-4770.2006 – ident: e_1_3_2_20_2 doi: 10.1038/nm1520 – ident: e_1_3_2_9_2 – ident: e_1_3_2_16_2 doi: 10.1038/nm0297-212 – ident: e_1_3_2_13_2 doi: 10.1038/ni1281 – ident: e_1_3_2_11_2 doi: 10.1084/jem.20031982 – ident: e_1_3_2_7_2 doi: 10.1128/JVI.01369-07 – ident: e_1_3_2_3_2 doi: 10.1128/JVI.01958-08 – ident: e_1_3_2_19_2 doi: 10.1086/514112 – ident: e_1_3_2_24_2 doi: 10.1128/JVI.00580-08 – ident: e_1_3_2_30_2 doi: 10.1073/pnas.94.5.1890 – ident: e_1_3_2_25_2 doi: 10.1128/JVI.77.12.6889-6898.2003 – ident: e_1_3_2_26_2 doi: 10.1128/JVI.00535-08 – ident: e_1_3_2_12_2 doi: 10.4049/jimmunol.174.12.7524 – ident: e_1_3_2_6_2 doi: 10.1128/JVI.02165-06 – ident: e_1_3_2_10_2 doi: 10.1097/QAD.0b013e3283021a8c – ident: e_1_3_2_33_2 doi: 10.1128/JVI.80.10.5074-5077.2006 – ident: e_1_3_2_5_2 doi: 10.1084/jem.20052319 – ident: e_1_3_2_14_2 doi: 10.1128/JVI.02392-06 – start-page: 312 year: 2008 ident: e_1_3_2_17_2 publication-title: 15th Conference on Retroviruses and Opportunistic Infection. – ident: e_1_3_2_27_2 doi: 10.1128/JVI.01471-08 – ident: e_1_3_2_8_2 doi: 10.1371/journal.ppat.0030094 – ident: e_1_3_2_32_2 doi: 10.1126/science.283.5403.857 – ident: e_1_3_2_34_2 doi: 10.1128/JVI.80.6.3122-3125.2006 – ident: e_1_3_2_29_2 doi: 10.1086/526786 – ident: e_1_3_2_18_2 doi: 10.1038/nm0496-405 – ident: e_1_3_2_28_2 doi: 10.1128/JVI.77.4.2736-2740.2003 – ident: e_1_3_2_22_2 doi: 10.1038/nm992 – ident: e_1_3_2_31_2 doi: 10.1128/jvi.68.4.2362-2370.1994 – ident: e_1_3_2_2_2 doi: 10.1038/35030124 – ident: e_1_3_2_23_2 doi: 10.1128/JVI.80.7.3617-3623.2006 – reference: 8207839 - J Virol. 1994 Jul;68(7):4650-5 – reference: 16501126 - J Virol. 2006 Mar;80(6):3122-5 – reference: 9018241 - Nat Med. 1997 Feb;3(2):212-7 – reference: 16641269 - J Virol. 2006 May;80(10):4758-70 – reference: 9359718 - J Infect Dis. 1997 Nov;176(5):1188-97 – reference: 9933172 - Science. 1999 Feb 5;283(5403):857-60 – reference: 17182686 - J Virol. 2007 Mar;81(5):2440-8 – reference: 16369537 - Nat Immunol. 2006 Feb;7(2):173-8 – reference: 11014195 - Nature. 2000 Sep 21;407(6802):386-90 – reference: 15944251 - J Immunol. 2005 Jun 15;174(12):7524-30 – reference: 18275276 - J Infect Dis. 2008 Feb 15;197(4):563-71 – reference: 17151109 - J Virol. 2007 Mar;81(5):2508-18 – reference: 14770175 - Nat Med. 2004 Mar;10(3):282-9 – reference: 9050875 - Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 – reference: - J Virol. 2010 Jan;84(2):1212 – reference: 15067030 - J Exp Med. 2004 Apr 5;199(7):905-15 – reference: 16537629 - J Virol. 2006 Apr;80(7):3617-23 – reference: 17728232 - J Virol. 2007 Nov;81(22):12608-18 – reference: 18562530 - J Virol. 2008 Sep;82(17):8422-30 – reference: 18971283 - J Virol. 2009 Jan;83(1):140-9 – reference: 8139022 - J Virol. 1994 Apr;68(4):2362-70 – reference: 17173051 - Nat Med. 2007 Jan;13(1):46-53 – reference: 18945771 - J Virol. 2009 Jan;83(1):88-97 – reference: 17616974 - PLoS Pathog. 2007 Jul;3(7):e94 – reference: 12552014 - J Virol. 2003 Feb;77(4):2736-40 – reference: 17251286 - J Virol. 2007 Apr;81(7):3465-76 – reference: 18580606 - AIDS. 2008 Jul 11;22(11):1277-86 – reference: 12768008 - J Virol. 2003 Jun;77(12):6889-98 – reference: 16641299 - J Virol. 2006 May;80(10):5074-7 – reference: 16682496 - J Exp Med. 2006 May 15;203(5):1357-69 – reference: 8597949 - Nat Med. 1996 Apr;2(4):405-11 – reference: 18596105 - J Virol. 2008 Sep;82(17):8548-59 |
SSID | ssj0014464 |
Score | 2.2142231 |
Snippet | Author's Correction
(
vol.
84
,
p.
1212
)
Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike... Elite controllers (EC) of human immunodeficiency virus type 1 (HIV-1) maintain viremia below the limit of detection without antiretroviral treatment.... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3407 |
SubjectTerms | Biological and medical sciences Epitopes, T-Lymphocyte - genetics Epitopes, T-Lymphocyte - immunology Fundamental and applied biological sciences. Psychology gag Gene Products, Human Immunodeficiency Virus - genetics HIV Infections - immunology HIV Infections - virology HIV Long-Term Survivors HIV-1 - genetics HIV-1 - immunology Human immunodeficiency virus 1 Humans Microbiology Miscellaneous Mutation, Missense - immunology nef Gene Products, Human Immunodeficiency Virus - genetics Pathogenesis and Immunity Plasma - virology pol Gene Products, Human Immunodeficiency Virus - genetics Polymorphism, Genetic Selection, Genetic Viral Load Viremia - immunology Virology |
Title | HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers |
URI | http://jvi.asm.org/content/83/7/3407.abstract https://www.ncbi.nlm.nih.gov/pubmed/19153230 https://www.proquest.com/docview/21304690 https://www.proquest.com/docview/67012640 https://pubmed.ncbi.nlm.nih.gov/PMC2655568 |
Volume | 83 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEBIviDsdMPwAT1VH49ycxzANtds6pGode7OcxNECI0VLgjR-Cr-Wc5w4SatOXF6iKnFSK9-X43N8boS8BZXaYQkLQPqpdOxEPshB5SiwWmOwJwLtGcNoi1NvunSOLtyLweBXL2qpKqP9-OfWvJL_QRXOAa6YJfsPyLYPhRPwG_CFIyAMx7_CeHoSjs37BcXxPMNs-3lVNuFt4TX2pMPp4K5GvV0_w3yQVaKwcITOuoSbqmKE5ujIwiCvEu_R4etXTXD8Ft0Vk-P62_Hz2XIRauhXxWV2U33NWjN_AWL7sHHsY6JZ54f6HJ4c13EYmmBd7PGHxaeD43l4anKJmv1WszcR9EJaunQAlFO9CNR51lWY6ktmNIpt3Wa4lcx1i5uGgX5PzNpO3Sq3WbJhJWbblwOGKQ5H57N99DDD9Hi37BlX_8Zq2MYowprugS3p3CF3me_rEAC9E9R4qMCMdkwlepy3Sapg_H3__9bVHVOCGiNwZQEfYVp3T9lm3mxG6fbUnrOH5EGDOQ1r8j0iA5U_JvfqDqY3T0i0TkGqKUhbCsJ9itYUpFlONQXpJgWppiBFClKLagrSHgWfkuXHw7OD6bhp2zGOXdstx5J7k8TlMpKx7VsSTNaIW6ACYZ2mIEpANHDQE_0Ue9FZ2uBIWQx6eKwCqazUtZ-RnXyVqxeEpilLpUxUlEjQoiY88ljgxY6na1Rxhw3JyLxdETc17bG1ypXQti3jArAQGgsx4UPyrh39va7lcsu4XQOUkMU38eVHJrgtfIG0G5K9NejaJxm-DMkbg6UAUY3-N5mrVVXACFvvRt0-wvNBX_QcGPG8xr6bZwDvidlwxV9jRTsAy8SvX8mzS10unnkulhnc_dPEX5L73Tf8iuyU15V6DRp3Ge1p6v8GtTvWpw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HLA-Associated+Viral+Mutations+Are+Common+in+Human+Immunodeficiency+Virus+Type+1+Elite+Controllers&rft.jtitle=Journal+of+virology&rft.au=MIURA%2C+Toshiyuki&rft.au=BRUMME%2C+Chanson+J&rft.au=WALKER%2C+Bruce+D&rft.au=BROCKMAN%2C+Mark+A&rft.date=2009-04-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.volume=83&rft.issue=7&rft.spage=3407&rft.epage=3412&rft_id=info:doi/10.1128%2FJVI.02459-08&rft.externalDBID=n%2Fa&rft.externalDocID=21261644 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |